Get started
Author

Anne‐Sophie W. Møller

Observed names: Anne-Sophie Moller, Anne-Sophie Møller, Anne-Sophie W Møller, Anne-Sophie W. Møller, Anne‐Sophie W. Møller
Institution: Targovax (Norway)
ORCID: 0009-0007-4507-1055
Observed ORCID: 0009-0007-4507-1055
OpenAlex ID: A5055496818
Combination of immunogenic oncolytic adenovirus ONCOS-102 with anti-PD-1 pembrolizumab exhibits synergistic antitumor effect in humanized A2058 melanoma huNOG mouse model
2018 · Lukasz Kuryk, Anne-Sophie W. Møller, et al. · OncoImmunology · 100
Chemokine Patterns in Meningococcal Disease
2005 · Anne‐Sophie W. Møller, Anna Bjerre, et al. · The Journal of Infectious Diseases · 89
TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial
2020 · Daniel H. Palmer, Juan W. Valle, et al. · British Journal of Cancer · 74
PDF
Complement Activation and Complement-Dependent Inflammation byNeisseria meningitidisAre Independent of Lipopolysaccharide
2004 · Tom Sprong, Anne-Sophie W. Møller, et al. · Infection and Immunity · 58
Abscopal effect when combining oncolytic adenovirus and checkpoint inhibitor in a humanized NOG mouse model of melanoma
2019 · Lukasz Kuryk, Anne‐Sophie W. Møller, et al. · Journal of Medical Virology · 47
PDF
Chimeric oncolytic Ad5/3 virus replicates and lyses ovarian cancer cells through desmoglein‐2 cell entry receptor
2020 · Lukasz Kuryk, Anne‐Sophie W. Møller · Journal of Medical Virology · 45
PDF
Antitumor‐specific T‐cell responses induced by oncolytic adenovirus ONCOS‐102 (AdV5/3‐D24‐GM‐CSF) in peritoneal mesothelioma mouse model
2018 · Lukasz Kuryk, Anne‐Sophie W. Møller, et al. · Journal of Medical Virology · 42
PDF
Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α) and the chemokine receptor CCR2 by purified human blood monocytes
2003 · Anne-Sophie W. Møller, Reidun Øvstebø, et al. · Journal of Endotoxin Research · 23
PDF
Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks
2019 · Lukasz Kuryk, Anne-Sophie W Møller, et al. · International Journal of Molecular Sciences · 21
PDF
Quantification and functional evaluation of CD40L production from the adenovirus vector ONCOS-401
2018 · Lukasz Kuryk, Anne-Sophie W. Møller, et al. · Cancer Gene Therapy · 20
Next generation oncolytic viruses expressing PADI1 and TIMP2 exhibit anti-tumor activity against melanoma in nude and humanized mouse models
2023 · Lukasz Kuryk, Anne-Sophie W. Møller · Molecular Therapy — Oncolytics · 12
PDF
Cardiomyocytes from postinfarction failing rat hearts have improved ischemia tolerance
2009 · Mohammad Nouri Sharikabad, Jan Magnus Aronsen, et al. · American Journal of Physiology-Heart and Circulatory Physiology · 10
361 A randomised open-label phase I/II study adding ONCOS-102 to pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 12 month analysis of biomarkers and clinical outcomes
2020 · Magnus Jaderberg, Susana Cedres, et al. · Journal for ImmunoTherapy of Cancer · 7
Non-Mannose-Capped Lipoarabinomannan Stimulates Human Peripheral Monocytes to Expression of the “Early Immediate Genes” Tissue Factor and Tumor Necrosis Factor-α
2001 · Anne-Sophie W. Møller, Kari Bente F. Haug, et al. · Thrombosis Research · 7
A non-randomised open-label exploratory ‘window of opportunity’ study of TG02 treatment in patients with locally advanced primary and recurrent RAS mutant colorectal cancer
2024 · Sara Roth, Kasmira Claire Wilson, et al. · Heliyon · 3
Using global gene expression patterns to characterize Annexin V positive and negative human monocytes in culture
2008 · Per Kr. Lund, Reidun Øvstebø, et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 3
Abstract 1983: Modulation of immune gene expression by intra-tumoral oncolytic adenovirus ONCOS-102 is associated with clinical response in anti-PD-1 refractory/resistant melanoma
2022 · Erik Digman Wiklund, Lukasz Kuryk, et al. · Cancer Research
368 Consistent pattern of immune activation induced by oncolytic adenovirus ONCOS-102 across diverse types of solid tumors
2021 · Lukasz Kuryk, Anne-Sophie Moller, et al. · Journal for ImmunoTherapy of Cancer
PDF
462 A randomised open-label phase I/II study adding ONCOS-102 to pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 24 month survival data
2021 · Magnus Jaderberg, Luis Paz-Ares, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract 4562: Next generation Oncos oncolytic adenovirus with novel anti-cancer double-transgenes shows synergistic anticancer effect in melanoma mouse model
2020 · Lukasz Kuryk, Anne-Sophie Moller · Cancer Research
Cover Image, Volume 92, Number 8, August 2020
2020 · Lukasz Kuryk, Anne‐Sophie W. Møller · Journal of Medical Virology
Works count: 21
Citation count: 561
H-index: 11
I10-index: 12
Year
Topic
Type